home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post navigation
Previous Post
Previous
Arvinas Appoints Paul McInulty as Senior Vice President, Regulatory Affairs
Next Post
Next
Theseus Pharmaceuticals Nominates THE-349, a Fourth-Generation EGFR Inhibitor Development Candidate in Non-Small Cell Lung Cancer